{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:20:06Z","timestamp":1774952406807,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.urolonc.2023.04.025","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T15:53:21Z","timestamp":1686930801000},"page":"356.e1-356.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The efficacy and timing of adjuvant chemotherapy in upper tract urothelial carcinoma"],"prefix":"10.1016","volume":"41","author":[{"given":"Hailong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renfu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2023.04.025_bib0001","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.025_bib0002","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12894-021-00876-7","article-title":"The incidence and prevalence of upper tract urothelial carcinoma: a systematic review","volume":"21","author":"Soualhi","year":"2021","journal-title":"BMC Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2023.04.025_bib0003","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2023.04.025_bib0004","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/JU.0000000000000644","article-title":"Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"203","author":"Margulis","year":"2020","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2023.04.025_bib0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clgc.2020.10.006","article-title":"Treatment of metastatic urothelial carcinoma after previous cisplatin-based chemotherapy for localized disease: a retrospective comparison of different chemotherapy regimens","volume":"19","author":"Do","year":"2021","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2023.04.025_bib0006","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.clgc.2021.02.001","article-title":"A single-arm phase II trial of neoadjuvant cabazitaxel and cisplatin chemotherapy for muscle-invasive transitional cell carcinoma of the urinary bladder","volume":"19","author":"Challapalli","year":"2021","journal-title":"Clin Genitourin Cancer"},{"issue":"10","key":"10.1016\/j.urolonc.2023.04.025_bib0007","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00345-017-2032-6","article-title":"Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study","volume":"35","author":"Nakagawa","year":"2017","journal-title":"World J Urol"},{"issue":"10232","key":"10.1016\/j.urolonc.2023.04.025_bib0008","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.urolonc.2023.04.025_bib0009","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1002\/cam4.3363","article-title":"Delayed initiation of adjuvant chemotherapy in older women with breast cancer","volume":"9","author":"Smith-Graziani","year":"2020","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.025_bib0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/annonc\/mdv500","article-title":"Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology\/Gynecologic Oncology Group study","volume":"27","author":"Tewari","year":"2016","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2023.04.025_bib0011","doi-asserted-by":"crossref","first-page":"75.e15","DOI":"10.1016\/j.urolonc.2019.11.001","article-title":"Timing of adjuvant chemotherapy and overall survival following radical cystectomy","volume":"38","author":"Jue","year":"2020","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.025_bib0012","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupret","year":"2021","journal-title":"European urology"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.025_bib0013","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1097\/CAD.0000000000001200","article-title":"Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data","volume":"33","author":"Ricci","year":"2022","journal-title":"Anticancer Drugs"},{"issue":"6","key":"10.1016\/j.urolonc.2023.04.025_bib0014","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s10147-020-01650-9","article-title":"Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis","volume":"25","author":"Quhal","year":"2020","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2023.04.025_bib0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jnci\/djaa090","article-title":"Body mass index and tumor-infiltrating lymphocytes in triple-negative breast cancer","volume":"113","author":"Floris","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.urolonc.2023.04.025_bib0016","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1042\/BST20210048","article-title":"Roles for growth factors and mutations in metastatic dissemination","volume":"49","author":"Nataraj","year":"2021","journal-title":"Biochem Soc Trans"},{"issue":"8","key":"10.1016\/j.urolonc.2023.04.025_bib0017","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1200\/JCO.2015.64.1076","article-title":"Effectiveness of adjuvant chemotherapy for locally advanced bladder cancer","volume":"34","author":"Galsky","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.025_bib0018","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12885-022-09688-w","article-title":"Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system","volume":"22","author":"Lu","year":"2022","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.urolonc.2023.04.025_bib0019","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1245\/s10434-015-4479-2","article-title":"Factors implicated for delay of adjuvant chemotherapy in colorectal cancer: a meta-analysis of observational studies","volume":"22","author":"Malietzis","year":"2015","journal-title":"Annal Surg Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2023.04.025_bib0020","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ejca.2010.01.020","article-title":"Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis","volume":"46","author":"Des Guetz","year":"2010","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"16","key":"10.1016\/j.urolonc.2023.04.025_bib0021","first-page":"3833","article-title":"Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta","volume":"117","author":"Lima","year":"2011","journal-title":"Canada. Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2023.04.025_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2020.100577","article-title":"Delaying adjuvant chemotherapy in advanced gastric cancer patients: risk factors and its impact on survival outcome","volume":"44","author":"Zhao","year":"2020","journal-title":"Curr Probl Cancer"},{"issue":"19","key":"10.1016\/j.urolonc.2023.04.025_bib0023","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/cncr.30163","article-title":"Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer","volume":"122","author":"Mirkin","year":"2016","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.urolonc.2023.04.025_bib0024","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/jamaoncol.2016.5829","article-title":"Association of delayed adjuvant chemotherapy with survival after lung cancer surgery","volume":"3","author":"Salazar","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.025_bib0025","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1245\/s10434-014-3949-2","article-title":"Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer","volume":"22","author":"Park","year":"2015","journal-title":"Annal Surg Oncol"},{"issue":"19","key":"10.1016\/j.urolonc.2023.04.025_bib0026","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.7150\/jca.58154","article-title":"Clinical impact of postoperative interval until adjuvant chemotherapy following curative gastrectomy for advanced gastric cancer","volume":"12","author":"Takashima","year":"2021","journal-title":"J Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2023.04.025_bib0027","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10120-019-00961-9","article-title":"Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset","volume":"22","author":"Nakanishi","year":"2019","journal-title":"Gastric Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2023.04.025_bib0028","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ejso.2017.01.008","article-title":"Timing of initiation of adjuvant chemotherapy for gastric cancer: a case-matched comparison study of laparoscopic vs. open surgery","volume":"43","author":"Kaito","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2023.04.025_bib0029","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/SLA.0000000000000378","article-title":"Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer","volume":"260","author":"Merkow","year":"2014","journal-title":"Annal Surg"},{"issue":"9","key":"10.1016\/j.urolonc.2023.04.025_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138720","article-title":"Factors affecting use and delay (\u22658 weeks) of adjuvant chemotherapy after colorectal cancer surgery and the impact of chemotherapy-use and delay on oncologic outcomes","volume":"10","author":"Kim","year":"2015","journal-title":"PloS one"},{"issue":"4","key":"10.1016\/j.urolonc.2023.04.025_bib0031","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/SLA.0b013e318211d7b5","article-title":"Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses","volume":"253","author":"Goldfarb","year":"2011","journal-title":"Annal Surg"},{"issue":"35","key":"10.1016\/j.urolonc.2023.04.025_bib0032","doi-asserted-by":"crossref","first-page":"e11954","DOI":"10.1097\/MD.0000000000011954","article-title":"Laparoscopic versus open nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and meta-analysis","volume":"97","author":"Liu","year":"2018","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.025_bib0033","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1186\/s12885-022-09767-y","article-title":"Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2023.04.025_bib0034","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2020.03.011","article-title":"Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial","volume":"147","author":"van der Valk","year":"2020","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2023.04.025_bib0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1078155220915767","article-title":"Adverse drug reactions associated with chemotherapeutic agents used in breast cancer: analysis of patients' online forums","volume":"27","author":"Assi","year":"2021","journal-title":"J Oncol Pharm Pract"},{"issue":"Suppl 2","key":"10.1016\/j.urolonc.2023.04.025_bib0036","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1136\/ejhpharm-2019-002162","article-title":"Exploring the adverse effects of chemotherapeutic agents used in the treatment of cervical and ovarian cancer from the patients' perspective: a content analysis of the online discussion forums","volume":"28","author":"Assi","year":"2021","journal-title":"Eur J Hosp Pharm"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923001436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923001436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:28:11Z","timestamp":1761042491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143923001436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1078143923001436"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.04.025","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and timing of adjuvant chemotherapy in upper tract urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}